Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Other financing activities: 2018-2024

Historic Other financing activities for Therapeutics (RAPT) over the last 7 years, with Dec 2024 value amounting to $19.9 million.

  • Therapeutics' Other financing activities rose 3.61% to $4.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $19.9 million, marking a year-over-year increase of 16.64%. This contributed to the annual value of $19.9 million for FY2024, which is 16.64% up from last year.
  • According to the latest figures from FY2024, Therapeutics' Other financing activities is $19.9 million, which was up 16.64% from $17.1 million recorded in FY2023.
  • In the past 5 years, Therapeutics' Other financing activities registered a high of $19.9 million during FY2024, and its lowest value of $8.7 million during FY2020.
  • Over the past 3 years, Therapeutics' median Other financing activities value was $17.1 million (recorded in 2023), while the average stood at $16.1 million.
  • Data for Therapeutics' Other financing activities shows a peak YoY soared of 323.50% (in 2020) over the last 5 years.
  • Therapeutics' Other financing activities (Yearly) stood at $8.7 million in 2020, then rose by 14.58% to $10.0 million in 2021, then increased by 13.18% to $11.3 million in 2022, then skyrocketed by 51.73% to $17.1 million in 2023, then climbed by 16.64% to $19.9 million in 2024.